Loading...
Home 2018-07-18T12:57:38+00:00

REVIVE

Welcome to REVIVE! Brought to you by GARDP’s Antimicrobial Memory Recovery & Exploratory Programme, REVIVE is a space for everybody with an interest in antimicrobial R&D.

Researchers and drug developers can connect with each other and with world-class experts from the golden age of antibiotic development.

Is your molecule novel? Is it “druggable”? Can it be optimized? Which bacteria needs targeting? What pitfalls should you watch out for? Find out this and more. Discuss with your peers from across the world, learn from our webinars, and ask our experts – here!

" In our webinar titled “Antibacterial drugs: Clinical development for non-developers Part 1: Traditional development – tiers A and B” with David Shlaes, we received more questions from the audience than we could answer during the session. See below one of the open audience questions. Please see find a recording of this webinar here. One webinar participant asked: Do you find Medicare’s New Technology Add-on Payment (NTAP) program helpful? If not, why not? What would it take to make the program workable? "

3 months ago

" In our recent webinar titled “PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?” with William Hope, we received more questions from the audience than we could answer during the session. We will now follow up on some remaining questions in the forum and encourage our experts but also users to discuss these questions. Please see find a recording of this webinar here. One webinar participant asked: Which is the best model for a new drug for UTI... "

5 months ago

" In our recent webinar titled “PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?” with William Hope, we received more questions from the audience than we could answer during the session. We will now follow up on some remaining questions in the forum and encourage our experts but also users to discuss these questions. Please see find a recording of this webinar here. One webinar participant asked: How important is consistency between the route of administration for treatment... "

5 months ago

ONE-TO-ONE DISCUSSION

Talk to an expert

Ask your question here and we will assign the best expert available to answer

Read more
Visit all Forums